Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Buy at StockNews.com
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday. Separately, HC Wainwright reaffirmed a “neutral” rating on shares of Oramed Pharmaceuticals in a research report on Monday, September 9th. Read Our Latest Stock Analysis on […]
20 Sep 01:58 · The Cerbat Gem